Skip to main content

LMR Partners LLP

Position in GILD — Gilead Sciences, Inc.

CIK 1578621 LONDON, X0

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,007,668
+$1,290,990 QoQ
Shares Held
15,891
+172.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#832
of 2,266 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 11% Shared 89% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2023
CallValue
$0
CallShares
0
PutValue
$10,126,250
PutShares
125,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. GILD ranks #10 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,007,668 15,891
2025-12-31 $716,678 5,839
2025-09-30 $285,270 2,570
2025-06-30 $3,557,152 32,084
2025-03-31 $1,559,959 13,922
2024-12-31 $5,246,523 56,799
2023-12-31 $10,126,250 125,000
2022-12-31 $2,319,323 27,016
2022-03-31 $2,344,529 39,437
2021-09-30 $5,536,171 79,258
2020-12-31 $713,102 12,240
2020-09-30 $1,116,188 17,664
2020-06-30 $5,870,675 76,302
2020-03-31 $4,901,265 65,560